Neil Stahl
2015
In 2015, Neil Stahl earned a total compensation of $18.4M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $594,000 |
|---|---|
| Option Awards | $17,209,995 |
| Salary | $550,000 |
| Other | $20,515 |
| Total | $18,374,510 |
Stahl received $17.2M in option awards, accounting for 94% of the total pay in 2015.
Stahl also received $594K in bonus, $550K in salary and $20.5K in other compensation.
Rankings
In 2015, Neil Stahl's compensation ranked 142nd out of 13,638 executives tracked by ExecPay. In other words, Stahl earned more than 99.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 142 out of 13,638 | 99th |
Division Manufacturing | 53 out of 5,187 | 99th |
Major group Chemicals And Allied Products | 26 out of 1,857 | 99th |
Industry group Drugs | 23 out of 1,531 | 99th |
Industry Pharmaceutical Preparations | 19 out of 1,179 | 98th |
Source: SEC filing on April 26, 2016.
Stahl's colleagues
We found four more compensation records of executives who worked with Neil Stahl at Regeneron Pharmaceuticals in 2015.
2015
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2015
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2015
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
2015
Robert Landry
Regeneron Pharmaceuticals